Sestrin2 ameliorates LPS-induced cardiomyocyte injury by inhibiting ferroptosis via the Nrf2/HO-1 pathway

This study demonstrates that Sesn2 inhibits ferroptosis in LPS-treated H9c2 cells through the Nrf2/HO-1 pathway, and also exerts an anti-apoptotic effect.

Authors

Institutions

Publication Details

Journal
European journal of medical research
Published
2025-11-28
DOI
https://doi.org/10.1186/s40001-025-03580-6
Primary Topic
Ferroptosis and cancer prognosis
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Sestrin2 ameliorates LPS-induced cardiomyocyte injury by inhibiting ferroptosis via the Nrf2/HO-1 pathway

Qingshan Tian, Yiheng Yang, Zhenzhong Zheng, Peng Yang
European journal of medical research
Ferroptosis and cancer prognosis
article

Sestrin2 ameliorates LPS-induced cardiomyocyte injury by inhibiting ferroptosis via the Nrf2/HO-1 pathway

Qingshan Tian, Yiheng Yang, Zhenzhong Zheng, Peng Yang
article en

Abstract

This study demonstrates that Sesn2 inhibits ferroptosis in LPS-treated H9c2 cells through the Nrf2/HO-1 pathway, and also exerts an anti-apoptotic effect.

European journal of medical researchVol. 31(1)
Nanchang University (CN), First Affiliated Hospital of Jiangxi Medical College (CN)
Openalex Percentile: Top 45%
Ferroptosis and cancer prognosis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.